Graeme Turnbull

Dr. Graeme Turnbull


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2014 in Chemical Communications
Verified
Journal Article
Open access
PDF file
GBGary Black
Gary Black
NBNicola L. Brown
Nicola L. Brown
JPJustin Perry
Justin Perry
PRP. David Randall
P. David Randall
GTGraeme Turnbull
Graeme Turnbull
MZMeng Zhang
Meng Zhang
We have developed a chromogenic reagent to show nitrilase activity and demonstrate its use with 23 enzymes as cell-free extracts.

16 February 2017 in Chemical Communications
Verified
Journal Article
Open access
PDF file
GTGraeme Turnbull
Graeme Turnbull
JWJ A Gareth Williams
J A Gareth Williams
VKValery Kozhevnikov
Valery Kozhevnikov
Appending a cyclometallated platinum unit onto each of the three ligands of the archetypal fac -Ir(ppy) 3 complex leads to a highly efficient red emitter with a short luminescence decay time.

14 July 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
JOJoseph O'SUllivan
Joseph O'SUllivan
JMJose Muñoz-Muñoz
Jose Muñoz-Muñoz
GTGraeme Turnbull
Graeme Turnbull
NSNeil Sim
Neil Sim
SPStuart Penny
Stuart Penny
SMSterghios A Moschos
Sterghios A Moschos
Nucleic Acid Therapeutics (NATs) are establishing a leading role for the management and treatment of genetic diseases following FDA approval of nusinersen, patisiran, and givosiran in the last 5 years, the breakthrough of milasen, with more approvals undoubtedly on the way. Givosiran takes advantage of the known interaction between the hepatocyte specific asialoglycoprotein receptor (ASGPR) and N-acetyl galactosamine (GalNAc) ligands to deliver a therapeutic effect, underscoring the value of targeting moieties. In this review, we explore the history of GalNAc as a ligand, and the paradigm it has set for the delivery of NATs through precise targeting to the liver, overcoming common hindrances faced with this type of therapy. We describe various complex oligosaccharides (OSs) and ask what others could be used to target receptors for NAT delivery and the opportunities awaiting exploration of this chemical space.

19 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
CWCong Wang
Cong Wang
DWDing Wang
Ding Wang
VKValery Kozhevnikov
Valery Kozhevnikov
XDXingyi Dai
Xingyi Dai
GTGraeme Turnbull
Graeme Turnbull
Ben XuBen Xu
Ben Xu
Elastic folding, a phenomenon widely existing in nature, has attracted great interests to understand the math and physical science behind the topological transition on surface, thus can be used to create frontier engineering solutions. Here, we propose a topo-optical sensing strategy with ultra-high contrast by programming surface folds on targeted area with a thin optical indicator layer. A robust and precise signal generation can be achieved under mechanical compressive strains (>0.4). This approach bridges the gap in current mechano-responsive luminescence mechanism, by utilizing the unwanted oxygen quenching effect of Iridium-III (Ir-III) fluorophores to enable an ultra-high contrast signal. Moreover, this technology hosts a rich set of attractive features such as high strain sensing, encoded logic function, direct visualisation and good adaptivity to the local curvature, from which we hope it will enable new opportunities for designing next generation flexible/wearable devices.

1 February 2014 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MCMarie Cellier
Marie Cellier
EFElizabeth Fazackerley
Elizabeth Fazackerley
AJArthur L. James
Arthur L. James
SOSylvain Orenga
Sylvain Orenga
JPJohn D. Perry
John D. Perry
SSStephen P. Stanforth
Stephen P. Stanforth

1 December 2015 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MCMarie Cellier
Marie Cellier
AGAmandine Gignoux
Amandine Gignoux
AJArthur L. James
Arthur L. James
SOSylvain Orenga
Sylvain Orenga
JPJohn D. Perry
John D. Perry
GTGraeme Turnbull
Graeme Turnbull